Geode Capital Management »

Lexeo Therapeutics shares owned by Geode Capital Management

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by Geode Capital Management from 13F filings

Historical chart of Geode Capital Management investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by Geode Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.1M 198k 15.68

More positions owned by Geode Capital Management

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Inc-class A Cl A (META)
Alphabet Inc-cl A Cap Stk Cl A (GOOGL)
Alphabet Inc-cl C Cap Stk Cl C (GOOG)
Berkshire Hathaway Inc-cl B Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Visa Inc-class A Shares Com Cl A (V)
UnitedHealth (UNH)
Exxon Mobil Corporation (XOM)

View all positions for Geode Capital Management

Top funds holding Lexeo Therapeutics

Eventide Asset Management
Henderson Group
Citadel Advisors
Omega Fund Management
Adage Capital Partners GP
Braidwell
Artal Group
Blackstone Group
BlackRock
RA Capital Management
Millennium Management
Vanguard Group
Laurion Capital Management
Geode Capital Management
Cornell University

View all funds holding Lexeo Therapeutics